The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma

BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jasmine YM, Rampaul, Rajendra Singh, Cheung, Kwok L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613396/
https://www.ncbi.nlm.nih.gov/pubmed/19046426
http://dx.doi.org/10.1186/1477-7819-6-128
_version_ 1782163175758626816
author Tang, Jasmine YM
Rampaul, Rajendra Singh
Cheung, Kwok L
author_facet Tang, Jasmine YM
Rampaul, Rajendra Singh
Cheung, Kwok L
author_sort Tang, Jasmine YM
collection PubMed
description BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast cancer has the opportunity to provide a means to initiate treatment in those patients who present with varying degrees of intestinal obstruction. CONCLUSION: Fulvestrant may obviate the use of chemotherapy while achieving sustained clinical benefit with less toxicity, in appropriately selected patients.
format Text
id pubmed-2613396
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26133962009-01-03 The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma Tang, Jasmine YM Rampaul, Rajendra Singh Cheung, Kwok L World J Surg Oncol Case Report BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast cancer has the opportunity to provide a means to initiate treatment in those patients who present with varying degrees of intestinal obstruction. CONCLUSION: Fulvestrant may obviate the use of chemotherapy while achieving sustained clinical benefit with less toxicity, in appropriately selected patients. BioMed Central 2008-12-01 /pmc/articles/PMC2613396/ /pubmed/19046426 http://dx.doi.org/10.1186/1477-7819-6-128 Text en Copyright © 2008 Tang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tang, Jasmine YM
Rampaul, Rajendra Singh
Cheung, Kwok L
The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
title The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
title_full The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
title_fullStr The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
title_full_unstemmed The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
title_short The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
title_sort use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613396/
https://www.ncbi.nlm.nih.gov/pubmed/19046426
http://dx.doi.org/10.1186/1477-7819-6-128
work_keys_str_mv AT tangjasmineym theuseoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma
AT rampaulrajendrasingh theuseoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma
AT cheungkwokl theuseoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma
AT tangjasmineym useoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma
AT rampaulrajendrasingh useoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma
AT cheungkwokl useoffulvestrantaparenteralendocrineagentinintestinalobstructionduetometastaticlobularbreastcarcinoma

Ejemplares similares